Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A small but variable subgroup of patients with myasthenia gravis (MG) who have antibodies to muscle-specific kinase (MuSKAb-MG) can present with distinct phenotypes and are often treatment-resistant. The prevalence, clinical phenotypes and outcomes of treatment of patients with MuSKAb-MG in Thailand were determined. Eight (16.3%) of the 49 patients with generalized MG who were negative for acetylcholine receptor antibodies (AChRAb) were positive for muscle-specific kinase antibodies. Most patients had predominant oculobulbar features and respiratory failure occurred in three. At follow up, three out of the seven patients who underwent thymectomy were in complete stable remission and four had improved and were on reduced immunosuppression medication, suggesting a possible benefit of thymectomy.

Original publication

DOI

10.1016/j.jocn.2012.03.047

Type

Journal article

Journal

J Clin Neurosci

Publication Date

05/2013

Volume

20

Pages

707 - 709

Keywords

Adult, Autoantibodies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myasthenia Gravis, Phenotype, Prevalence, Receptor Protein-Tyrosine Kinases, Receptors, Cholinergic, Thailand, Thymectomy, Treatment Outcome